abstract |
The present disclosure provides improved compositions containing rifabutin, clarithromycin and clofazimine for the treatment of Inflammatory Bowel Diseases. In one example, these compositions are capsules, tablets, etc. with one or more specific additives. may contain a formulation of rifabutin, clarithromycin and clofazimine in single dose form such as. |